Alleged False Claims Act Violation: Unnecessary Drug Testing a Red Flag for Feds

Alleged False Claims Act Violation: Unnecessary Drug Testing a Red Flag for Feds

Earlier this month, a toxicology lab doing business as Precision Diagnostics agreed to pay $27 million to resolve allegations raised by three whistleblowers under the False Claims Act that it charged Medicare and Medicaid for medically unnecessary urine drug tests and also paid kickbacks to get testing referrals.

To overbill Medicare, the complaint alleges, Precision Diagnostics used “custom profiles,” which acted as functional standing orders that led doctors to order a wide array of urine testing without assessing individual needs. Many of these tests were expensive and alleged to be medically unnecessary.

Urine drug testing has been a focus of U.S. Department of Justice (DOJ) enforcement efforts recently, including as a part of treatment of the opioid epidemic, which has proven to be especially vulnerable to various types of healthcare fraud. Put differently, and channeling David Glaser, Monitor Monday’s punster-in-chief, DOJ resolutions of whistleblower-initiated allegations of urine testing fraud have been coming at a steady stream.

Earlier this year, Labtox agreed to pay $10.4 million to settle similar allegations, with two of its executives going to prison, including one for nearly four years. In 2021, Colorado-based laboratory Cordant Health Solutions paid nearly $1 million to resolve similar allegations, and Nevada Advanced Pain Specialists, a Reno-based medical practice, paid $1 million for allegedly medically unnecessary urine drug testing. In 2023, a drug testing laboratory called Solid Diagnostics paid the State of Vermont $400,000 to settle the same type of fraud.   

For drug testing, there are two main categories of testing, “qualitative” and “quantitative.”  A qualitative test, more commonly known as a screen, is generally a binary test that determines the presence of a drug and costs around $50. In contrast, a quantitative test, which costs hundreds of dollars, determines the amount of a drug in a patient’s system. Jumping straight to quantitative tests, when a qualitative test would have been sufficient and more cost-effective, may violate the False Claims Act.

In addition to being accused of medically unnecessary urine drug testing, Precision Diagnostics also settled kickback allegations as part of the recent $27 million settlement with DOJ. Federal officials accused Precision Diagnostics of handing out free equipment to doctors expressly conditioned on the agreement to use Precision for its testing.

Kickbacks are not a new theory of liability in the urine drug testing world. In 2020, laboratories operated by Cordant Health Solutions in Washington and Colorado paid nearly $12 million to resolve allegations that the labs paid millions to a physician group in exchange for referrals.

The Precision Diagnostics recovery resulted from three qui tam cases brought by three separate whistleblowers under the False Claims Act, a law that allows private individuals to sue in the name of the government and share in the recovery. Billions are recovered under the False Claims Act annually, with doubtless billions more of fraud deterred.

One of the whistleblowers in the Precision Diagnostics matter will receive just under $3 million as their whistleblower award. As an editorial footnote, I’m pleased to report that my colleagues at Whistleblower Partners LLP represented one of the three brave whistleblowers involved in this case.

Needless to say, I’m proud of them, and most importantly, of our whistleblower client, for their role in achieving this important result.

Facebook
Twitter
LinkedIn

Mary Inman, Esq.

Mary Inman is a partner and co-founder of Whistleblower Partners LLP, a law firm dedicated to representing whistleblowers under the various U.S. whistleblower reward programs. Mary and her colleagues have pioneered a series of successful whistleblower cases against prominent health insurers, hospitals, provider groups, and vendors under the False Claims Act alleging manipulation of the risk scores of Medicare Advantage patients. Mary is a recognized expert and frequent author, commentator, and speaker on frauds in the healthcare industry, particularly those exposed by whistleblowers. Mary is a member of the RACmonitor editorial board and a popular panelist on Monitor Monday.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Enhancing Outcomes with CDI-Coding-Quality Collaboration in Acute Care Hospitals

Enhancing Outcomes with CDI-Coding-Quality Collaboration in Acute Care Hospitals

Join Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, as she presents effective strategies to strengthen collaboration between CDI, coding, and quality departments in acute care hospitals. Angela will also share guidance on implementing cross-departmental meetings, using shared KPIs, and engaging leadership to foster a culture of collaboration. Attendees will gain actionable tools to optimize documentation accuracy, elevate quality metrics, and drive a unified approach to healthcare goals, ultimately enhancing both patient outcomes and organizational performance.

November 21, 2024
Comprehensive Inpatient Clinical Documentation Integrity: From Foundations to Advanced Strategies

Comprehensive Outpatient Clinical Documentation Integrity: From Foundations to Advanced Strategies

Optimize your outpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to outpatient CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. You will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.

September 5, 2024
Advanced Outpatient Clinical Documentation Integrity: Mastering Complex Narratives and Compliance

Advanced Outpatient Clinical Documentation Integrity: Mastering Complex Narratives and Compliance

Enhancing outpatient clinical documentation is crucial for maintaining accuracy, compliance, and proper reimbursement in today’s complex healthcare environment. This webcast, presented by industry expert Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, will provide you with actionable strategies to tackle complex challenges in outpatient documentation. You’ll learn how to craft detailed clinical narratives, utilize advanced EHR features, and implement accurate risk adjustment and HCC coding. The session also covers essential regulatory updates to keep your documentation practices compliant. Join us to gain the tools you need to improve documentation quality, support better patient care, and ensure financial integrity.

September 12, 2024

Trending News

Featured Webcasts

Patient Notifications and Rights: What You Need to Know

Patient Notifications and Rights: What You Need to Know

Dr. Ronald Hirsch provides critical details on the new Medicare Appeal Process for Status Changes for patients whose status changes during their hospital stay. He also delves into other scenarios of hospital patients receiving custodial care or medically unnecessary services where patient notifications may be needed along with the processes necessary to ensure compliance with state and federal guidance.

December 5, 2024
Navigating the No Surprises Act & Price Transparency: Essential Insights for Compliance

Navigating the No Surprises Act & Price Transparency: Essential Insights for Compliance

Healthcare organizations face complex regulatory requirements under the No Surprises Act and Price Transparency rules. These policies mandate extensive fee disclosures across settings, and confusion is widespread—many hospitals remain unaware they must post every contracted rate. Non-compliance could lead to costly penalties, financial loss, and legal risks.  Join David M. Glaser Esq. as he shows you how to navigate these regulations effectively.

November 19, 2024
Post Operative Pain Blocks: Guidelines, Documentation, and Billing to Protect Your Facility

Post Operative Pain Blocks: Guidelines, Documentation, and Billing to Protect Your Facility

Protect your facility from unwanted audits! Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, and take a deep dive into both the CMS and AMA guidelines for reporting post operative pain blocks. You’ll learn how to determine if the nerve block is separately codable with real life examples for better understanding. Becky will also cover how to evaluate whether documentation supports medical necessity, offer recommendations for stronger documentation practices, and provide guidance on educating providers about documentation requirements. She’ll include a discussion of appropriate modifier and diagnosis coding assignment so that you can be confident that your billing of post operative pain blocks is fully supported and compliant.

October 24, 2024
The OIG Update: Targets and Tools to Stay in Compliance

The OIG Update: Targets and Tools to Stay in Compliance

During this RACmonitor webcast Dr. Ronald Hirsch spotlights the areas of the OIG’s Work Plan and the findings of their most recent audits that impact utilization review, case management, and audit staff. He also provides his common-sense interpretation of the prevailing regulations related to those target issues. You’ll walk away better equipped with strategies to put in place immediately to reduce your risk of paybacks, increased scrutiny, and criminal penalties.

September 19, 2024

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →